AstraZeneca PLC CEDEAR (AZN)
BCBA
Closed
Aug 21, 2026
Day's Range
65,275.0052 wk Range
50,650.00Overview - AZN - AstraZeneca PLC CEDEAR
Key Statistics
Valuation
Enterprise Value
1,852,263.10T
P/E (Trailing)
‪6.53‬
PEG Ratio
‪3.44‬
Price / Sales (TTM)
‪1,673.68‬
Price / Book
‪16.43‬
EV / EBITDA
‪62,176.31‬
Profitability
Gross Margin
‪83.59%‬
Profit Margin
‪17.02%‬
Operating Margin
‪23.45%‬
Return on Assets
‪8.01%‬
Return on Equity
‪21.96%‬
Ownership
Shares Outstanding
1.55B
Float
18.58B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0060%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪67,685.50‬
200-Day Avg
‪69,957.38‬
Dividends
Payout Ratio
‪11.97%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AZN - AstraZeneca PLC CEDEAR
Peers - AZN - AstraZeneca PLC CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- AZNBCBAAstraZeneca PLC CEDEAR101.00TMarket Cap+18.54%52-week change6.36P/E (Trailing)‪17.02%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,355.89TMarket Cap+43.62%52-week change60.24P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR345.82TMarket Cap+43.38%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR167.51TMarket Cap+35.56%52-week change17.39P/E (Trailing)‪14.52%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt74.64TMarket Cap+33.95%52-week change7.75P/E (Trailing)‪9.80%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.72.76TMarket Cap+40.06%52-week change5.24P/E (Trailing)‪18.87%‬Profit Margin
- GILDBCBAGilead Sciences Inc.72.10TMarket Cap+33.02%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
Profile Summary - AZN - AstraZeneca PLC CEDEAR
About
AstraZeneca PLC CEDEAR is a certificate representing shares of AstraZeneca PLC, a Swedish-British multinational pharmaceutical and biotechnology company headquartered in Cambridge, United Kingdom. The company focuses on the discovery, development, manufacture, and commercialization of prescription medicines across key…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
